Soliris 300 MG/30 ML vial 30ML
Ended Awarded
- Contract number
- SPE2DX25F6XUW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $59,918
Award facts
- Contract value 100% obligated
- $59,918.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Defense Medical Supply Chain awarded a delivery order valued at $59,918.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Soliris 300 mg/30 ml vials. This firm fixed-price delivery order, issued on September 26, 2025, is scheduled for completion by October 20, 2025, with performance taking place in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 through November 2026. The IDC enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. As a consistently successful federal contractor, DMS Pharmaceutical Group has established itself as a critical supplier within the military pharmaceutical supply chain, with a robust portfolio of specialized pharmaceutical product deliveries spanning oncology treatments, biologics, and specialty medications to support military health operations.
Quick answers
Who was awarded contract SPE2DX25F6XUW?
SPE2DX25F6XUW was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 26, 2025.
How much is contract SPE2DX25F6XUW worth?
The government has obligated $59,918 on SPE2DX25F6XUW.
Is contract SPE2DX25F6XUW an order under another contract?
Yes. SPE2DX25F6XUW is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XUW competed?
The extent of competition for SPE2DX25F6XUW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award